Todd Bazemore

EVP & Chief Commercial Officer, DYAX CORP.

Companies

Kala Pharmaceuticals (United States)Board member Sep 2, 2025 to now¹
Kala Pharmaceuticals (United States)Officer Jan 5, 2022 to now²
Pulmatrix, Inc.Board member Oct 2, 2020 to Jan 30, 2023³
Kala Pharmaceuticals (United States)Chief operating officer Nov 21, 2017 to Oct 28, 2021⁴

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Kala Pharmaceuticals (United States) KALA35,933 shares⁵$6.9K at $0.19Oct 24, 2025

As of each latest filing. The line shows shares held over time.

Oct 22, 2025Sold 47,768 shares at $0.83 of Kala Pharmaceuticals (United States)⁵
Jun 24, 2025Sold 4,058 shares at $4.01 of Kala Pharmaceuticals (United States)⁶
Jun 3, 2025Sold 3,390 shares at $3.74 of Kala Pharmaceuticals (United States)⁷
Jan 6, 2025Sold 1,993 shares at $7.63 of Kala Pharmaceuticals (United States)⁸
Jan 6, 2025Granted 10,100 shares of Kala Pharmaceuticals (United States)⁸
Jun 26, 2024Sold 4,653 shares at $4.75 of Kala Pharmaceuticals (United States)⁹
May 31, 2024Sold 2,093 shares at $6.09 of Kala Pharmaceuticals (United States)¹⁰
Jan 4, 2024Sold 1,405 shares at $6.74 of Kala Pharmaceuticals (United States)¹¹
Jan 4, 2024Granted 6,500 shares of Kala Pharmaceuticals (United States)¹¹
Jun 22, 2023Granted 48,698 shares of Kala Pharmaceuticals (United States)¹²
May 31, 2023Granted 21,158 shares of Kala Pharmaceuticals (United States)¹³
Jan 4, 2023Sold 62 shares at $28.54 of Kala Pharmaceuticals (United States)¹⁴
Jan 4, 2023Granted 12,800 shares of Kala Pharmaceuticals (United States)¹⁴
Oct 26, 2022Sold 214 shares at $6.51 of Kala Pharmaceuticals (United States)¹⁵
Jun 27, 2022Sold 3,092 shares at $0.37 of Kala Pharmaceuticals (United States)¹⁶
Jan 4, 2022Sold 3,454 shares at $1.30 of Kala Pharmaceuticals (United States)¹⁷
Oct 26, 2021Sold 12,544 shares at $1.80 of Kala Pharmaceuticals (United States)¹⁸

The numbers on this page point here. Each one links to the record it came from.